Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Glywel-M
Glywel-M Gliclazide & Metformin Hydrochloride Tablets is a combination therapy for type 2 diabetes mellitus, designed to provide effective glycemic control. By combining two complementary mechanisms, insulin secretion stimulation and insulin sensitivity enhancement, Glywel-M helps patients achieve stable blood sugar levels. It is prescribed when diet and exercise alone do not provide adequate glucose control.
Uses of Glywel-M
Glywel-M is indicated for the treatment of:
Type 2 Diabetes Mellitus
Poorly Controlled Blood Glucose Levels
Diabetes with Insulin Resistance
Prevention of Diabetes-Related Complications
Benefits of Glywel-M
Dual Mechanism for Superior Glycemic Control
Enhances Insulin Sensitivity and Lowers Glucose Production
Reduces the Risk of Diabetes-Related Complications
Helps Maintain Long-Term Blood Sugar Stability
Convenient Combination Therapy to Improve Adherence
Mechanism of Action of Glywel-M
Glywel-M contains two active ingredients:
Gliclazide (Sulfonylurea): Stimulates pancreatic beta cells to release more insulin, thereby lowering blood glucose levels.
Metformin Hydrochloride (Biguanide): Reduces hepatic glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity in peripheral tissues.